Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Primary amine functional groups (-NH2) are fundamental chemical moieties found on the side chains of lysine residues and the N-termini of proteins (PubChem, CID 6339). They serve as critical nucleophiles in biological systems, participating in enzymatic reactions such as the formation of Schiff base intermediates in transamination (NCBI, Bookshelf NBK22524). In a physiological context, these groups are essential for maintaining protein structure through hydrogen bonding and are frequently involved in post-translational modifications. While not a specific therapeutic target, these groups are the primary site for the formation of advanced glycation end-products (AGEs), which contribute to vascular complications in diabetes and aging (PubMed, PMID 24354186). In biotechnology, primary amines are the most common targets for bioconjugation, reacting with reagents like N-hydroxysuccinimide (NHS) esters to create antibody-drug conjugates (PubMed, PMID 26010316). Chemical modifiers such as glutaraldehyde or formaldehyde also target these groups to facilitate protein cross-linking or inactivation for sterilization and vaccine production. However, the ubiquitous nature of primary amines across the entire proteome makes them poor targets for systemic drugs due to a lack of specificity. Targeting these groups covalently can lead to significant safety concerns, including the formation of immunogenic drug-protein adducts and systemic toxicity (PubMed, PMID 11741362).
Covalent modification via nucleophilic attack, Schiff base formation, or acylation to alter protein function, facilitate bioconjugation, or induce cross-linking.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Primary amine functional group (NH2).